Literature DB >> 21214329

Clinicopathological factors related to regrowth of vestibular schwannoma after incomplete resection.

Masafumi Fukuda1, Makoto Oishi, Tetsuya Hiraishi, Manabu Natsumeda, Yukihiko Fujii.   

Abstract

OBJECT: The authors retrospectively analyzed various clinicopathological factors to determine which are related to regrowth during a long-term follow-up period in patients who underwent incomplete vestibular schwannoma (VS) resection.
METHODS: This study involved 74 patients (25 men and 49 women) in whom a VS was treated surgically via the lateral suboccipital approach, and who had postoperative follow-up periods exceeding 5 years. The mean follow-up was 104.1 months (range 60-241 months), and the mean patient age at surgery was 48.1 years (range 19-75 years). The tumors ranged in size from 0 mm (localized within the internal auditory canal) to 56 mm (28.3 ± 12.2 mm [mean ± SD]).
RESULTS: Gross-total resection (GTR) was performed in 41 (55%) of the 74 patients; subtotal resection ([STR]; 90-99%) in 25 (34%); and partial resection ([PR]; < 90%) in 8 (11%). Regrowth rates in the GTR, STR, and PR groups were 2.4% (1 of 41 cases), 52% (13 of 25), and 62.5% (5 of 8), respectively, and the times to regrowth ranged from 6 to 76 months (median 31.9 months). The regrowth-free survival curves differed significantly between the complete (GTR) and incomplete (STR and PR) resection groups. Eighteen (54.5%) of the 33 patients who underwent incomplete resection showed evidence of regrowth during follow-up. Univariate and multivariate analyses of various factors revealed that both the thickness of the residual tumor, based on MR imaging after surgery, and the MIB-1 index were positively related to residual tumor regrowth. The receiver operating characteristic curves, plotted for both the thickness of the residual tumor and the MIB-1 index, identified the optimal cutoff points for these values as 7.4 mm (sensitivity 83.3%, specificity 86.7%) and 1.6 (sensitivity 83.3%, specificity 66.7%), respectively.
CONCLUSIONS: Greater residual tumor thickness, based on MR imaging after the initial surgery, and a higher MIB-1 index are both important factors related to postoperative tumor regrowth in patients who have undergone incomplete VS resection. These patients require frequent neuroimaging investigation during follow-up to assure early detection of tumor regrowth.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21214329     DOI: 10.3171/2010.11.JNS101041

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  21 in total

1.  Surgical treatment of acoustic neuroma: Outcomes and indications.

Authors:  Elisabetta Zanoletti; Chiara Faccioli; Alessandro Martini
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-07

2.  Microsurgical Management of Trigeminal Schwannoma: Cohort Analysis and Systematic Review.

Authors:  Maick Willen Fernandes Neves; Paulo Henrique Pires de Aguiar; Telmo Augusto Barba Belsuzarri; André Monteiro Soares de Araujo; Samantha Lorena Paganelli; Marcos Vinicius Calfat Maldaun
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-28

3.  Increased growth rate of vestibular schwannoma after resection of contralateral tumor in neurofibromatosis type 2.

Authors:  Matthieu Peyre; Stephane Goutagny; Sandrine Imbeaud; Alexis Bozorg-Grayeli; Michele Felce; Olivier Sterkers; Michel Kalamarides
Journal:  Neuro Oncol       Date:  2011-07-28       Impact factor: 12.300

4.  Management of large and giant vestibular schwannomas.

Authors:  Irumee Pai; James Bowman; Nick Thomas; Neil Kitchen; Anthony Strong; Rupert Obholzer; Michael Gleeson
Journal:  Skull Base       Date:  2011-11

Review 5.  Evaluating growth trends of residual sporadic vestibular schwannomas: a systematic review and meta-analysis.

Authors:  Abdullah Egiz; Hritik Nautiyal; Andrew F Alalade; Nihal Gurusinghe; Gareth Roberts
Journal:  J Neurooncol       Date:  2022-06-27       Impact factor: 4.506

6.  The fate of spinal schwannomas following subtotal resection: a retrospective multicenter study by the Korea spinal oncology research group.

Authors:  Seil Sohn; Chun Kee Chung; Sung-Hye Park; Eun-Sang Kim; Ki-Jeong Kim; Chi Heon Kim
Journal:  J Neurooncol       Date:  2013-06-30       Impact factor: 4.130

7.  Subtotal resection of vestibular schwannoma: Evaluation with Ki-67 measurement, magnetic resonance imaging, and long-term observation.

Authors:  Giannicola Iannella; Marco de Vincentiis; Cira Di Gioia; Raffaella Carletti; Benedetta Pasquariello; Alessandra Manno; Diletta Angeletti; Ersilia Savastano; Giuseppe Magliulo
Journal:  J Int Med Res       Date:  2017-04-27       Impact factor: 1.671

8.  COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake.

Authors:  Felix Behling; Vanessa Ries; Marco Skardelly; Irina Gepfner-Tuma; Martin Schuhmann; Florian-Heinrich Ebner; Ghazaleh Tabatabai; Antje Bornemann; Jens Schittenhelm; Marcos Tatagiba
Journal:  Acta Neuropathol Commun       Date:  2019-07-11       Impact factor: 7.801

9.  Prediction of vestibular schwannoma recurrence using artificial neural network.

Authors:  Mehdi Abouzari; Khodayar Goshtasbi; Brooke Sarna; Pooya Khosravi; Trevor Reutershan; Navid Mostaghni; Harrison W Lin; Hamid R Djalilian
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-02-17

10.  The impact of the MIB-1 index on facial nerve outcomes in vestibular schwannoma surgery.

Authors:  Johannes Wach; Simon Brandecker; Agi Güresir; Patrick Schuss; Hartmut Vatter; Erdem Güresir
Journal:  Acta Neurochir (Wien)       Date:  2020-03-09       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.